The eConsent Implementation Guide created and published by EUCROF’s eClinical Forum Electronic Informed Consent Joint Task Force has been shortlisted as a finalist in the Innovation award category at the TOPRA Awards.

Published in 2021, the guide aims to break down barriers to implementing eConsent processes in early phase research. It illustrates the efficiencies these advanced, electronic ways of working can provide to CROs, sponsors and regulators, and the benefits to volunteers. 

The pandemic emphasised the importance of discovering new, virtual processes and considers the practical implications of eConsent for all stakeholders.

Richmond Pharmacology has been actively involved in EUCROF, the European CRO Federation since its inception. Providing expert insight into medical research, the practical aspects of regulation and helping to shape the future of clinical trial industry. 

We look forward to the winner being announced during the in-person ceremony on 18th November 2021.  

You can read the guide here – eConsent Implementation Guide

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event